HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mahsa Moradipour Selected Research

GDC-0623

1/2020Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitors in triple-negative breast cancer cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mahsa Moradipour Research Topics

Disease

1Neoplasms (Cancer)
01/2020
1Triple Negative Breast Neoplasms
01/2020

Drug/Important Bio-Agent (IBA)

1GDC-0623IBA
01/2020
1LigninIBA
01/2020

Therapy/Procedure

1Therapeutics
01/2020